Videos

Josef Coresh, MD, PhD, discusses how primary care clinicians can address hypertension, diabetes, and smoking to support long-term cognitive health.

"Weighing Surgical Versus Medical Management in Endometriosis" takes up the question of when a patient's endometriosis care should shift from medicine to the operating room.

The panel of experts examines how the CATALYST trial is changing the way primary care clinicians recognize hypercortisolism in patients with difficult-to-control type 2 diabetes.

Patients who keep missing treatment goals despite good therapy may be facing an unrecognized hormonal driver that primary care is now positioned to catch early.

In "Understanding the Different Types of Endometriosis Lesions," our experts turn to the primary goals of treatment and the disease's four distinct subtypes.

Corresponding author Josef Coresh, MD, PhD, explains how hypertension, diabetes, and smoking in midlife were linked to fewer dementia-free survival years.

In "ACOG's New Guidance on Diagnosing Endometriosis Without Surgery," Dr. Davitt reflects on what ACOG's March 2026 guideline update means in daily practice.

In "Why Endometriosis Diagnosis Is Often Delayed by a Decade," the panel unpacks the factors behind a diagnostic delay that can stretch a decade.

Prebiotic sodas contain less sugar than regular soda and fruit drinks, but a new analysis finds they still lag diet soda and sparkling water on sugar content.

A Harvard-led analysis of more than 200,000 US adults found healthy plant-based diets lowered cardiometabolic risk regardless of ultra-processed food content.

Identifying who is most at risk for endometriosis, and recognizing its hallmark symptoms early, can shorten the path to diagnosis and reduce its enormous economic toll.

Endometriosis affects far more women than commonly cited figures suggest, and the gap between perception and reality shapes how the disease is diagnosed and treated.

Primary care faces a colorectal cancer screening backlog. Mark Fendrick, MD, describes noninvasive testing and mandatory colonoscopy follow-up.

Ruth Benca, MD, PhD, and Adam Spira, PhD, discuss how sleep disturbances, especially sleep apnea, may drive dementia risk and what to ask patients.

SLEEP 2026: A sleep expert discusses screening tools, referral pathways, and why sleep disorders matter for cardiometabolic health in primary care.

Tirzepatide, nerve stimulation, and oral AD109 are reshaping OSA care as phenotyping replaces the one-size-fits-all CPAP default.

Sairam Parthasarathy, MD, discusses late-breaking research he presented at SLEEP 2026 that showed hypoglossal nerve stimulation outperformed CPAP to improve OSA.

Patients with OSA who cannot tolerate CPAP may benefit from discussions about oral appliances, HNS, and other treatment options. Sairam Parthasarathy, MD, dives deeper.

SLEEP 2026: Virend Somers, MD, PhD, details how busy primary care physicians can address sleep in routine visits.

SLEEP 2026: Virend Somers, MD, of Mayo Clinic, outlines why sleep has been added to the AHA's Life’s Essential 8.

Laura B. Herpel, MD, reviews REFRESH trial data on once-nightly oxybate in narcolepsy, focusing on daytime function, stimulant reduction, and mental health.

Patil reviews 3 new AASM guidelines at SLEEP 2026 covering updated CSA treatment, first-ever inpatient OSA guidance, and chronic insomnia therapy hierarchy.

Andrew Ho, MD, reviews single-center data showing GLP-1 coverage barriers reshaped OSA referral patterns, with symptom documentation absent in most cases.

Baker explains how smartwatch sleep data can open clinical conversations about menopausal sleep disturbance but emphasizes the importance of patient-reported outcomes.

A 28-day smartwatch study in menopausal women found sleep fragmentation varied from night to night while total sleep time remained stable.

Wearable sleep tracker use was linked to better sleep in patients with insomnia and COMISA, while OSA showed a divergent pattern warranting further study.

Mander highlights sleep as a modifiable dementia risk factor, emphasizing sleep apnea diagnosis and treatment to support brain health.

Emerging data link sleep disorder severity to Alzheimer's biomarker accumulation, with small CPAP studies suggesting partial biomarker reversibility with treatment.

Pauline Maki, PhD, reviews data showing over half of elinzanetant's sleep benefit in postmenopausal women is independent of VMS reduction.

From behavioral therapy to NK3 receptor antagonists, Baker outlines an expanding toolkit for menopausal sleep disturbance.